Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion service announced it has acquired CIVIC Infusion, a company dedicated to delivering safe, convenient, and affordable solutions for infusion patients in Connecticut and New York. With this acquisition, Vivo Infusion will advance to a combined 36 ambulatory infusion centers across nine states. In connection with the transaction, CIVIC’s co-founders Barry D. Stein, MD, and Robert M. Roteman, MD will join Vivo Infusion as Medical Directors. Financial terms of the transaction were not disclosed.
Founded in 2018, CIVIC provides an affordable and accessible solution to the high cost of infusion care. Offering a wide array of therapies for acute and chronic medical conditions in a variety of specialties such as allergy/immunology, gastroenterology, neurology, and rheumatology, CIVIC prides itself on its holistic and multidisciplinary approach to infusion care. Its board-certified physicians work collaboratively with certified infusion nurses to provide the highest quality medical care to both adult and pediatric patients.
“We are excited to welcome the CIVIC Infusion team to the Vivo family,” said Chris Reef, Chief Executive Officer of Vivo Infusion. “CIVIC Infusion shares our commitment to providing exceptional and affordable care to patients with compassion and professionalism. Drs. Stein and Roteman have built a leading company in their local communities with an excellent reputation that we look forward to building upon. Together, with CIVIC Infusion, we will continue our mission of providing the best expert care while simultaneously reaching more infusion patients throughout the country.”
“We founded CIVIC Infusion with the belief that there was a better solution for infusion patients than the traditionally high-cost hospital setting and variable home treatment option,” said Dr. Stein. “We are pleased to offer patients, and referring physicians, a high-quality and affordable alternative. We are confident that the leadership at Vivo Infusion will accelerate our growth strategy and further our goal of helping build a better future for infusion patients and referring physicians.”
“Combining with Vivo Infusion is the next step in our growth journey, and we are thrilled and fortunate to have their support and partnership,” said Dr. Roteman. “The leadership team at Vivo Infusion brings deep expertise in the infusion care market and a relentless focus on providing exceptional patient experiences. We are pleased to partner with a company that upholds our same values, and we look forward to growing together.”
About Vivo Infusion
Vivo Infusion is a leading provider of accessible, affordable, community-based infusion and injection care for patients suffering from compromised immune systems, infectious diseases, and other medical conditions. Vivo Infusion provides compassionate, expert care administered in safe, accessible facilities using efficient and cost-effective, patient-focused best practices. Vivo currently serves communities in Colorado, Connecticut, Florida, Ohio, Oklahoma, Pennsylvania, New Jersey, New York, and Texas, with plans to expand into additional states. For more information, visit: www.vivoinfusion.com.
About CIVIC Infusion
CIVIC Infusion is dedicated to delivering safe, convenient, and affordable care for infusion patients. The centers have been designed specifically with the infusion patient in mind and boast state-of-the-art amenities in a warm, inviting atmosphere throughout Connecticut and New York. They are committed to setting the industry standard of excellence in care and customer service. For more information, please visit: www.civicinfusion.com.
In 2023, the M&A market for healthcare companies continues to build on STRATEGIC opportunities in the current market. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
